Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Surgical Procedures, Operative × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hepatic Veno-Occlusive Disease 1 Head and Neck Neoplasms 1 HER2-positive Early Breast Cancer 1 Germinoma 1

Interventions

pembrolizumab 30 Paclitaxel 12 Carboplatin 10 Cisplatin 7 Pemetrexed 5 Capecitabine 5 Saline Solution 4 Oxaliplatin 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3 lenvatinib 3 Leucovorin 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 liposomal doxorubicin 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trastuzumab deruxtecan 1 tislelizumab 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡